CLEANCART C Panama - Tiếng Anh - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

cleancart c

gambro lundia ab - Ácido cÍtrico anhidro - Ácido cÍtrico anhidro....32 g

PHOXILIUM 1.2MMOL/I SOL. FOR HAEMODIAL./HAEMOFILT Solution for haemodialysis/haemofiltration Ả Rập Xê-út - Tiếng Anh - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

phoxilium 1.2mmol/i sol. for haemodial./haemofilt solution for haemodialysis/haemofiltration

gambro lundia ab, sweden - sodium chloride,calcium chloride,magnesium chloride,potassium chloride,disodium phosphate - solution for haemodialysis/haemofiltration - 6.44,3.68,2.44,0.314,0.225 g,

BICART 720 Panama - Tiếng Anh - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

bicart 720

gambro dasco s.p.a - bicarbonato de sodio - bicarbonato de sodio ....720 g.

KALILACTASOL Unknown Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

kalilactasol unknown

gambro lundia ab - sodium chloride calcium chloride dihydrate magnesium chloride hexahydrate potassium chloride sodium lactate glucose - unknown

METRONIDAZOLE/METROVEX Solution for Infusion 500/100 Mg/Ml Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

metronidazole/metrovex solution for infusion 500/100 mg/ml

gambro northern ireland limited - metronidazole - solution for infusion - 500/100 mg/ml

KALILACTASOL %v/v Unknown Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

kalilactasol %v/v unknown

gambro lundia ab - sodium chloride calcium chloride dihydrate magnesium chloride hexahydrate potassium chloride sodium lactate glucose - unknown - %v/v

METRONIDAZOLE/METROVEX 500/100 Mg/Ml Solution for Infusion Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

metronidazole/metrovex 500/100 mg/ml solution for infusion

gambro northern ireland limited - metronidazole - solution for infusion - 500/100 mg/ml

Prismasol 2 mmol/l Potassium solution for haemofiltration and haemodialysis Malta - Tiếng Anh - Medicines Authority

prismasol 2 mmol/l potassium solution for haemofiltration and haemodialysis

gambro lundia ab - magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, lactic acid, calcium chloride, dihydrate, potassium chloride, glucose anhydrous - solution for haemofiltration - magnesium chloride hexahydrate 0.102 millimole(s)/litre ; sodium chloride 6.128 millimole(s)/litre ; sodium hydrogen carbonate 2.936 millimole(s)/litre ; lactic acid 0.27 millimole(s)/litre ; calcium chloride dihydrate 0.257 millimole(s)/litre ; potassium chloride 0.149 millimole(s)/litre ; glucose anhydrous 1.1 millimole(s)/litre - blood substitutes and perfusion solutions

PHOXILLUM  BK4/2.5- calcium chloride, magnesium chloride, sodium chloride, potassium chloride, sodium phosphate, dibasic, and so Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

phoxillum bk4/2.5- calcium chloride, magnesium chloride, sodium chloride, potassium chloride, sodium phosphate, dibasic, and so

gambro renal products - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), sodium phosphate, dibasic (unii: gr686lba74) (sodium cation - unii:lyr4m0nh37, phosphate i - calcium chloride 0.139 g in 1 l - prismasol and phoxillum solutions are indicated in pediatric and adult patients for use as a replacement solution in continuous renal replacement therapy (crrt) to replace plasma volume removed by ultrafiltration and to correct electrolyte and acid-base imbalances.they may also be used in case of drug poisoning when crrt is used to remove dialyzable substances. none pregnancy category c animal reproduction studies have not been conducted with prismasol and phoxillum solutions. while there are no adequate and well controlled studies in pregnant women, appropriate administration of prismasol and phoxillum solutions with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to cause fetal harm, or affect reproductive capacity. maintenance of normal acid-base balance is important for fetal well-being. the components of prismasol and phoxillum solutions are excreted in human milk. appropriate administration of prismasol and phoxillum solutions with monitoring of fluid, electrolyte, acid-